Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Pain

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...

Local Anesthetics: Clinical Application as Epidural Anesthesia

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Use of electronic health data to identify patients with moderate-to-severe osteoarthritis of the hip and/or knee and inadequate response to pain medications.

BMC medical research methodology·2023

Same author

Editorial: Pain 360: Emerging topics in the pathophysiology, diagnosis, and treatment of chronic pain.

Frontiers in pain research (Lausanne, Switzerland)·2023

Same author

Exploiting Injury-Induced Peripheral Opioid Receptor Changes in Novel Analgesic Development for Chronic Pain.

Frontiers in pain research (Lausanne, Switzerland)·2022

Same author

Dual-Acting Peripherally Restricted Delta/Kappa Opioid (CAV1001) Produces Antinociception in Animal Models of Sub-Acute and Chronic Pain.

Journal of pain research·2020

Same author

Passing the Baton, Once Again.

Pain practice : the official journal of World Institute of Pain·2017

Same author

The Opioid Epidemic: Root Cause Analysis.

Pain practice : the official journal of World Institute of Pain·2016

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Development of Recombinant Proteins to Treat Chronic Pain

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

Tapentadol immediate-release for acute pain.

Craig T Hartrick¹

¹Anesthesiology Research, Oakland University William Beaumont School of Medicine, 3601 W. 13 Mile Rd., Royal Oak, MI 48073, USA. chartrick@beaumont.edu

Expert Review of Neurotherapeutics

|June 4, 2010

Summary

Tapentadol offers effective pain relief through a dual mechanism, showing fewer gastrointestinal issues than oxycodone. Its favorable pharmacokinetic profile suggests better tolerability and reduced interaction risks.

Area of Science:

Pharmacology
Pain Management
Drug Development

Background:

Tapentadol is a novel analgesic with a dual mechanism of action.
Opioid analgesics are crucial for managing moderate-to-severe acute pain.
Understanding comparative tolerability and safety profiles is essential for clinical practice.

Purpose of the Study:

To highlight the unique dual mode of analgesic action of tapentadol.
To compare the gastrointestinal adverse effects of tapentadol with oxycodone.
To evaluate the pharmacokinetic advantages of tapentadol regarding metabolites, protein binding, and drug interactions.

Main Methods:

Pharmacological analysis of tapentadol's dual mechanism (norepinephrine reuptake inhibition and mu-opioid agonism).
Comparative assessment of gastrointestinal adverse effects against equianalgesic doses of oxycodone.

More Related Videos

Characteristics of Pain Changes in Rats with Nerve Injury Within 24 hours After One-Time Tuina Intervention

Characteristics of Pain Changes in Rats with Nerve Injury Within 24 hours After One-Time Tuina Intervention

Published on: January 26, 2024

Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Published on: March 24, 2023

Related Experiment Videos

Last Updated: Jun 12, 2026

Development of Recombinant Proteins to Treat Chronic Pain

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

Characteristics of Pain Changes in Rats with Nerve Injury Within 24 hours After One-Time Tuina Intervention

Characteristics of Pain Changes in Rats with Nerve Injury Within 24 hours After One-Time Tuina Intervention

Published on: January 26, 2024

Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Published on: March 24, 2023

Evaluation of tapentadol's pharmacokinetic properties: active metabolites, protein binding, and potential for accumulation in renal/hepatic impairment.

Main Results:

Tapentadol exhibits a dual mechanism, combining norepinephrine inhibition with opioid agonism.
Fewer gastrointestinal adverse effects were observed with tapentadol compared to oxycodone at equianalgesic doses.
Tapentadol has no active metabolites, minimal protein binding, and a lower potential for drug interactions or accumulation.

Conclusions:

Tapentadol presents an improved tolerability profile for acute pain management.
The dual action and favorable pharmacokinetics of tapentadol offer advantages over traditional opioids like oxycodone.
Tapentadol immediate-release is approved for moderate-to-severe acute pain in adults, offering a valuable therapeutic option.